or Try an Advanced Search...

    Technical Analysis for LIFE - aTyr Pharma, Inc.

    Grade Last Price % Change Price Change
    D 1.73 -1.70% -0.03
    LIFE closed down 1.7 percent on Friday, May 31, 2024, on 43 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: Jun 5
    *** please verify all earnings dates ***
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical LIFE trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    50 DMA Resistance Bearish 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    20 DMA Resistance Bearish -1.70%
    50 DMA Resistance Bearish -1.70%
    Outside Day Range Expansion -1.70%
    Fell Below 20 DMA Bearish 2.98%
    Fell Below 50 DMA Bearish 2.98%
    MACD Bearish Signal Line Cross Bearish 2.98%
    Older End-of-Day Signals for LIFE ...

       Recent Intraday Alerts

    Alert Time
    Down 2 % 1 day ago
    60 Minute Opening Range Breakdown 1 day ago
    Down 1% 1 day ago
    Reversed from Up 1 day ago
    Rose Above 10 DMA 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    LIFE Chart by TradingView
    Basic chart:

    Profile

    aTyr Pharma, Inc. engages in the discovery and clinical development of protein based therapeutics for patients suffering from severe and rare diseases. The company is developing Resolaris, which is in Phase Ib/II clinical trials in adult patients with facioscapulohumeral muscular dystrophy, a rare genetic myopathy with an immune component. Its products pipeline also includes Resolaris for treatment of patients with early onset facioscapulohumeral muscular dystrophy, a rare genetic myopathy with an immune component and limb-girdle muscular dystrophies, as well as rare pulmonary diseases with an immune component. In addition, the company is developing iMod.Fc, a preclinical immuno-modulatory domain program. The company was founded in 2005 and is headquartered in San Diego, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Organ Systems Clinical Development Rare Diseases Dystrophy Muscular Dystrophy Pulmonary Disease Myopathy Musculoskeletal System Severe And Rare Diseases Facioscapulohumeral Muscular Dystrophy Muscular Dystrophies Limb Girdle Muscular Dystrophies

    Is LIFE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 24 aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    May 15 aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference
    May 14 aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
    May 6 aTyr Pharma to Present at Upcoming Investor Conferences
    May 2 aTyr Pharma GAAP EPS of -$0.23 beats by $0.02, revenue of $0.24M beats by $0.22M
    May 2 aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
    Apr 21 aTyr Pharma Insiders Placed Bullish Bets Worth US$514.6k
    Apr 1 aTyr Pharma to Participate in April Investor Conferences
    Mar 26 3 Penny Stocks That Could Be Multibaggers in the Making: March Edition
    Mar 16 aTyr Pharma Full Year 2023 Earnings: Revenues Disappoint
    See more LIFE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.45
    52 Week Low 1.0801
    Average Volume 488,258
    200-Day Moving Average 1.59
    50-Day Moving Average 1.77
    20-Day Moving Average 1.79
    10-Day Moving Average 1.84
    Average True Range 0.11
    RSI (14) 46.52
    ADX 18.83
    +DI 20.67
    -DI 19.94
    Chandelier Exit (Long, 3 ATRs) 1.75
    Chandelier Exit (Short, 3 ATRs) 1.88
    Upper Bollinger Bands 2.04
    Lower Bollinger Band 1.55
    Percent B (%b) 0.37
    BandWidth 27.13
    MACD Line 0.01
    MACD Signal Line 0.03
    MACD Histogram -0.017
    Fundamentals Value
    Market Cap 101.31 Million
    Num Shares 58.6 Million
    EPS -0.95
    Price-to-Earnings (P/E) Ratio -1.82
    Price-to-Sales 10.89
    Price-to-Book 1.17
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.97
    Resistance 3 (R3) 1.99 1.93 1.93
    Resistance 2 (R2) 1.93 1.87 1.92 1.92
    Resistance 1 (R1) 1.83 1.83 1.80 1.81 1.91
    Pivot Point 1.77 1.77 1.76 1.76 1.77
    Support 1 (S1) 1.67 1.71 1.64 1.65 1.55
    Support 2 (S2) 1.61 1.67 1.60 1.54
    Support 3 (S3) 1.51 1.61 1.53
    Support 4 (S4) 1.49